TN2010000469A1 - 2-9 diamino pyrimidin 5 yl carboxamides as syk or jak kinases inhibitors - Google Patents

2-9 diamino pyrimidin 5 yl carboxamides as syk or jak kinases inhibitors

Info

Publication number
TN2010000469A1
TN2010000469A1 TNP2010000469A TN2010000469A TN2010000469A1 TN 2010000469 A1 TN2010000469 A1 TN 2010000469A1 TN P2010000469 A TNP2010000469 A TN P2010000469A TN 2010000469 A TN2010000469 A TN 2010000469A TN 2010000469 A1 TN2010000469 A1 TN 2010000469A1
Authority
TN
Tunisia
Prior art keywords
syk
methods
jak kinase
carboxamides
jak kinases
Prior art date
Application number
TNP2010000469A
Other languages
French (fr)
Inventor
Shawn M Bauer
Zhaozhong J Jia
Yonghong Song
Qing Xu
Mukund Mehrotra
Jack W Rose
Wolin Huang
Chandrasekar Venkataramani
Anjali Pandey
Original Assignee
Portola Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2009/002420 external-priority patent/WO2009145856A1/en
Application filed by Portola Pharm Inc filed Critical Portola Pharm Inc
Publication of TN2010000469A1 publication Critical patent/TN2010000469A1/en

Links

Abstract

The present invention is directed to compounds of formula I-II and pharmaceutically acceptable tautomers, salts, or stereoisomers thereof which are inhibitors of syk and/or JAK kinase. The present invention is also directed to intermediates used in making such compounds, the preparation of such a compound, pharmaceutical compositions containing such a compound, methods of inhibition syk and/or JAK kinase activity, methods of inhibition the platelet aggregation, and methods to prevent or treat a number of conditions mediated at least in part by syk and/or JAK kinase activity, such as cardiovascular disease, inflammatory disease, autoimmune disease and cell proliferative disorder, thrombosis, allergy, asthma, rheumatoid arthritis, leukemia, or non-Hodgkin's lymphoma.
TNP2010000469A 2009-04-16 2010-10-14 2-9 diamino pyrimidin 5 yl carboxamides as syk or jak kinases inhibitors TN2010000469A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2009/002420 WO2009145856A1 (en) 2008-04-16 2009-04-16 2, 6-diamino-pyrimidin- 5-yl-carboxamides as syk or jak kinases inhibitors

Publications (1)

Publication Number Publication Date
TN2010000469A1 true TN2010000469A1 (en) 2012-05-24

Family

ID=55024580

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2010000469A TN2010000469A1 (en) 2009-04-16 2010-10-14 2-9 diamino pyrimidin 5 yl carboxamides as syk or jak kinases inhibitors

Country Status (1)

Country Link
TN (1) TN2010000469A1 (en)

Similar Documents

Publication Publication Date Title
MY155639A (en) 2, 6-diamino-pyrimidin-5-yl-carboxamides as syk or jak kinases inhibitors
NZ589315A (en) 2,6-diamino-pyrimidin-5-yl-carboxamides as Spleen tryosine kinase (syk) or Janus kinase (JAK) inhibitors
MX2010011464A (en) 2, 6-diamino-pyrimidin- 5-yl-carboxamides as syk or jak kinases inhibitors.
MY156727A (en) N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
MD4735C1 (en) Pyrrolo[2,3-d]pyrimidine derivatives as inhibitors of Janus-related Kinases (JAK)
MX2014000354A (en) Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions.
EP3363797A8 (en) Oral dosage form of apoptosis signal-regulating kinase inhibitors
NZ588830A (en) Inhibitors of protein kinases
WO2009136995A3 (en) 2, 6-diamino- pyrimidin- 5-yl-carboxamides as syk or jak kinases inhibitors
MX2013012776A (en) Amino-pyridine-containing spleen tyrosine kinase (syk) inhibitors.
AU2012258977A8 (en) Inhibitors of LRRK2 kinase activity
MX2012009074A (en) Pyrrolo [ 2, 3 - d] pyrimidine urea compounds as jak inhibitors.
JO3398B1 (en) 2,3-Dihydro-benzo[1,4]oxazine derivatives and related compounds as phosphoinositide-3 kinase (PI3K) inhibitors for the treatment of e.g. rheumatoid arthritis
MX2013012983A (en) Compositions and methods for the production of pyrimidine and pyridine compounds with btk inhibitory activity.
WO2012054364A3 (en) Bicyclic diamines as janus kinase inhibitors
MX2012007175A (en) Imidazopyridine derivatives as jak inhibitors.
NZ629432A (en) Heterocyclyl compounds as mek inhibitors
MX2014004473A (en) 5,7-substituted-imidazo[1,2-c]pyrimidines.
MX2014000635A (en) Pyridin-2(1h)-one derivatives as jak inhibitors.
MX2013008296A (en) Diarylacetylene hydrazide containing tyrosine kinase inhibitors.
TN2011000404A1 (en) Fused pyrimidines
SG10201805392YA (en) 1,2,4-triazine-6-carboxamide kinase inhibitors
SG195106A1 (en) Trpv4 antagonists
MX363551B (en) Pyrazine kinase inhibitors.
MX2011011764A (en) Carboxamide compounds and their use as calpain inhibitors.